A complete account of how each Saltora formulation moves from supplier engagement to finished batch — and how the documentation at each stage is archived, maintained, and retained.
Every ingredient engagement begins with a request for documentation. No supplier proceeds to a commercial relationship without first providing a certificate of composition for the specific raw material being discussed. That certificate is reviewed against the elemental profile requirements for the relevant formulation before any order is placed.
Sourcing prioritises suppliers whose facilities maintain food-grade processing standards throughout their production chain. The chain-of-custody record — covering origin, transit conditions, and storage specifications — is reviewed as part of the initial engagement and archived alongside the certificate of composition. Suppliers whose documentation is incomplete at this stage are not engaged further.
Supplier documentation review — Jakarta, 2023
Each Saltora formulation is assembled from a review of published nutritional research. The inclusion of each micronutrient requires a documented role in normal human physiological function — not a market preference, not a label expectation. The elemental ratio within a formulation is calibrated against established daily intake guidelines and reviewed against the depletion profile of the intended user group.
The formulation work for the Complete Performance Complex occupied fourteen months. During that period, the ingredient list was reduced three times as certain inclusions could not meet the documented-role requirement. The final twelve were each accompanied by at least two independent published sources supporting their inclusion in the elemental profile.
Serving size decisions are made conservatively. The Saltora standard is to err toward a serving size that a man can sustain daily without disruption to his routine — which is why two of the three formulations remain at two capsules daily, rather than expanding to three or four as ingredient counts increase.
Formulation calibration notes — revision 07-A
Production takes place at the Saltora Jakarta facility. Each production run generates a lot record that references the specific source materials used, the granulation date, the encapsulation batch, and the quantity produced. The lot record is the primary traceability document — it is created during production, not assembled retrospectively.
Capsule shells used across all three formulations are vegetable-derived. The granulation process for each batch is documented with weight-per-capsule verification data. Batch-coded containers are assigned lot numbers that correspond to the production lot record before any unit leaves the facility.
Before any batch enters dispatch inventory, a sample unit is submitted to an independent laboratory for elemental analysis. The laboratory is external to the Saltora production facility and has no commercial relationship with the production or sourcing functions. The analysis verifies active ingredient concentrations against the stated elemental profile and confirms that label quantities are within acceptable tolerance.
Ingredient profiles in Saltora supplements are selected based on published nutritional research and undergo independent batch verification for quality and labelling accuracy. The outcome of each analysis is recorded on the lot record by batch reference number. Batches that do not pass analysis at the first submission are quarantined, the production documentation is reviewed, and a second submission is made only after the source of variance has been identified and resolved.
Independent batch analysis — revision 04-B
The complete production documentation set — sourcing certificates, lot records, granulation data, encapsulation records, lot code assignments, independent laboratory analysis reports, and any revision notes — is archived under a structured documentation system. The archive is maintained for a minimum of five years from each production date.
Each archive entry is indexed by batch reference number and includes a revision history. If a formulation is amended — for instance, if an ingredient ratio is adjusted in response to a new published source — the revision is logged with a new revision number and dated. The original specification is not deleted; it is marked as superseded and retained within the same batch reference file.
The archive currently covers twelve production batches across the three Saltora formulations. All twelve have passed independent batch analysis on first submission. The documentation framework has not changed since its first revision in 2022.
The supplier standard applied to every Saltora ingredient source has not changed since the first production cycle. Active ingredients are sourced from documented suppliers, with each batch accompanied by a certificate of composition. Sourcing prioritises suppliers whose facilities maintain food-grade processing standards.
The standard is not communicated as an aspiration — it is the entry condition for commercial engagement. Suppliers who have supplied to the Saltora range have all submitted documentation at or above this threshold. There are no exceptions on file.
Required for every active ingredient on every order. No certificate — no engagement.
Origin, transit conditions, and storage specifications — reviewed at engagement, archived with the certificate.
Facilities must maintain food-grade processing throughout the production chain, not only at the point of sale.
All supplier documentation is held in the Saltora archive alongside production records for the batches in which those ingredients were used.
Quality control at Saltora follows a defined sequence that does not compress under production pressure. The sequence is: granulation verification, weight-per-capsule check, encapsulation sample review, lot code assignment, and — before dispatch — independent laboratory submission.
The granulation verification step involves weighing a minimum of thirty capsules from each encapsulation run and recording each weight in the lot record. The weight-per-capsule tolerance is set at plus or minus two percent of the target fill weight. Capsules outside that tolerance are removed from the batch.
The independent laboratory submission follows the encapsulation review. A minimum of ten capsules from the batch are submitted — not a single unit, but a sample that allows the laboratory to account for within-batch variation. The laboratory's analysis report is received and reviewed before any dispatch authorisation is issued. There is no batch that has been dispatched ahead of receiving a complete analysis report.
Ask us about a specific batch record
Quality-control bench — Saltora Jakarta facility
Archive commenced
2022
First lot record entered at Jakarta facility opening. Framework revision: 01-A.
Batches on record
12 verified
Across three formulations. All passed independent analysis on first submission.
Retention policy
5 years minimum
From each production date. No batch record has been deleted since archive commencement.
Saltora products are nutritional food-supplements registered with the applicable local regulatory authority under food-supplement classification. Products meet compositional and labelling requirements for nutritional supplement categories.
Ingredient profiles in Saltora supplements are selected based on published nutritional research and undergo independent batch verification for quality and labelling accuracy.
We recommend speaking with a qualified wellness or nutrition professional before introducing any supplement to your daily routine, particularly if you have specific dietary requirements.
Batch documentation enquiries can be submitted through the contact form. Provide the batch reference number from the product label and specify the document type requested. The team will respond within three working days. Note that full laboratory analysis reports are provided in summary form due to third-party confidentiality obligations; the lot record reference and verification outcome are available in full.
From production completion to dispatch authorisation, the Saltora verification cycle typically takes between ten and fourteen working days. The majority of that time is the laboratory turnaround for the independent analysis. No batch is dispatched ahead of receiving the full analysis report, regardless of production scheduling pressure.
The laboratory used for Saltora batch analysis is selected on the basis of its independence from the production and sourcing functions, its analytical capability for the micronutrient profile being tested, and its documentation practices. The same laboratory has been used since the first Saltora batch in 2022. No production or sourcing personnel are involved in the analysis process.
Formulation changes are infrequent and require a documented rationale. Any revision to an elemental profile requires a review of the supporting literature and a confirmation that the revised profile remains within established daily intake guidelines. Revisions are logged with a new revision number, dated, and retained alongside the original specification in the archive. Since 2022, no formulation has undergone more than two minor revisions.
The methodology described on this page applies equally to all three Saltora compositions — Foundation Complex, Active Performance Complex, and Complete Performance Complex. Each has its own archive entry and full batch documentation on file.